Odatroltide
N/A
Report date: 2025/12/25 15:59:13
NME
Base Information
Drug NameOdatroltide
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesLumosa Therapeutics Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesPharmacore Biotech Co LtdLumosa Therapeutics Co LtdShanghai Pharmaceuticals Holding Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A